Latest & greatest articles for osteoarthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoarthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoarthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoarthritis

581. Economic evaluation of meloxicam (7.5mg) versus sustained release diclofenac (100mg) treatment for osteoarthritis: a cross-national assessment for France, Italy and the UK

be hypothesized that the costs associated with adverse effects of OA treatment could be considerably reduced. Source of funding Grants from Boehringer Ingelheim. Bibliographic details Jansen, Capri S, Nuijten M J, Burrell, Marini M G, Hardens M. Economic evaluation of meloxicam (7.5mg) versus sustained release diclofenac (100mg) treatment for osteoarthritis: a cross-national assessment for France, Italy and the UK. British Journal of Medical Economics 1997; 11: 9-22 Other publications of related interest (...) Economic evaluation of meloxicam (7.5mg) versus sustained release diclofenac (100mg) treatment for osteoarthritis: a cross-national assessment for France, Italy and the UK Economic evaluation of meloxicam (7.5mg) versus sustained release diclofenac (100mg) treatment for osteoarthritis: a cross-national assessment for France, Italy and the UK Economic evaluation of meloxicam (7.5mg) versus sustained release diclofenac (100mg) treatment for osteoarthritis: a cross-national assessment for France

1997 NHS Economic Evaluation Database.

582. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment

Authors' objectives To compare the effects of education interventions and non-steroidal anti-inflammatory drug (NSAID) treatment on pain and functional disability in patients with osteoarthritis, and on pain, functional disability, and tender joint counts in patients with rheumatoid arthritis. Searching Studies of educational interventions: MEDLINE was searched from 1966 to 1993 (the search terms are provided); bibliographies of relevant articles and of a previous meta-analysis were examined. Studies (...) in the review Patients with osteoarthritis or rheumatoid arthritis were included. Outcomes assessed in the review Pain, functional disability and tender joint counts were assessed. How were decisions on the relevance of primary studies made? The authors do not state how the papers were selected for the review, or how many of the authors performed the selection. Assessment of study quality The authors do not state that they assessed quality. Data extraction The standardised gain difference was used

1996 DARE.

583. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip

the Arthritis Foundation. Bibliographic details Chang R W, Pellissier J M, Hazen G B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. Journal of the American Medical Association 1996; 275(11): 858-865 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Age Factors; Aged; Aged, 80 and over; Cost-Benefit Analysis; Data Collection; Decision Trees; Disease Progression; Female; Hip Prosthesis /economics /mortality; Humans; Male; Middle Aged; Models, Economic (...) all the requirementsof a quality cost-effectiveness analysis. Implications of the study Further research is needed to determine whether this procedure is actually being used in this cost-effective manner, especially in older age groups. Source of funding The study was supported by National Institutes of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases Multipurpose Arthritis and Musculoskeletal Diseases grant, National Science Foundation grant, and a grant form

1996 NHS Economic Evaluation Database.

584. The efficacy of aerobic exercises for treating osteoarthritis of the knee

commentary Overall, this is a poorly designed review, constructed from 3 RCTs that suffer from methodological problems such as a potential sampling bias (i.e. use of volunteers) and failure to blind outcome assessors. One study included patients with both osteoarthritis and rheumatoid arthritis of both the hip and knee joint, and it is unclear if the data relevant to this review was available separately. Since the search strategy was limited to English language papers, relevant literature may have been (...) The efficacy of aerobic exercises for treating osteoarthritis of the knee The efficacy of aerobic exercises for treating osteoarthritis of the knee The efficacy of aerobic exercises for treating osteoarthritis of the knee La Mantia K, Marks R Authors' objectives To critically examine the efficacy of aerobic exercise for treating osteoarthritis of the knee. Searching MEDLINE was searched from 1985 to 94 with search terms (explode) 'arthritis', (explode) 'osteoarthritis', 'exercise', (explode

1995 DARE.

585. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. Full Text available with Trip Pro

, Australia.25 patients (median age 64 years) with pain of osteoarthritis (median duration of disease eight years) considered by their general practitioners to require regular treatment. 20 were already taking non-steroidal anti-inflammatory drugs.Diary of pain and stiffness, function, and side effects.15 patients completed the study, five withdrew early but had made a therapeutic decision, and five dropped out very early. Results from 20 patients were analysed. Several patterns of response evolved. Eight (...) n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. To evaluate the efficacy of paracetamol and a non-steroidal anti-inflammatory drug for symptom relief in osteoarthritis.Double blind, randomised, controlled trials in individual patients (n of 1 trials). Three treatment cycles with two weeks' each of paracetamol (1 g twice daily) and diclofenac (50 mg twice daily) prepared in identical gelatin capsules.General practices in metropolitan Sydney

1994 BMJ Controlled trial quality: uncertain

586. Taping the patella medially: a new treatment for osteoarthritis of the knee joint? Full Text available with Trip Pro

Taping the patella medially: a new treatment for osteoarthritis of the knee joint? To test the hypothesis that medial taping of the patella reduces the symptoms of osteoarthritis of the knee when the patellofemoral joint is affected.Randomised, single blind, crossover trial of three different forms of taping of the knee joint. Each tape (medial, lateral, or neutral) was applied for four days, with three days of no treatment between tape positions.14 patients with established, symptomatic (...) in patients with osteoarthritis of the patellofemoral joint.

1994 BMJ Controlled trial quality: uncertain

587. Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol

Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol Bentkover J D, Baker A M, Kaplam H Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) type Cost-effectiveness analysis Study population Elderly patients (> 60 years of age) with osteoarthritis. Setting Primary care. The economic study was carried out in the USA. Dates to which data relate Cost data was calculated for 1992 US dollars, and effectiveness data was gathered from a trial conducted in 1993. Source of effectiveness data The evidence for effectiveness was derived from a single study. Link between effectiveness and cost data Cost data was not collected on patients included

1994 NHS Economic Evaluation Database.

588. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis

for hip and knee osteoarthritis. Annals of Internal Medicine 1994; 121(2): 133-140 PubMedID Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Clinical Trials as Topic; Humans; Knee Joint; Osteoarthritis /therapy; Osteoarthritis, Hip /therapy AccessionNumber 11994008036 Date bibliographic record published 31/01/1998 Date abstract record published 31/01/1998 Record Status This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each (...) Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis Puett D W, Griffin M R Authors' objectives To review the efficacy of nonmedicinal, noninvasive therapies in knee and hip osteoarthritis. Searching MEDLINE was searched from 1966 to 1993 by cross-referencing the medical therapy

1994 DARE.

589. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. (Abstract)

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. The optimal short-term, symptomatic therapy for osteoarthritis of the knee has not been fully determined. Accordingly, we compared the efficacy of a nonsteroidal antiinflammatory drug, ibuprofen, given in either an antiinflammatory dose (high dose) or an analgesic dose (low dose), with that of acetaminophen, a pure analgesic.In (...) a randomized, double-blind trial, 184 patients with chronic knee pain due to osteoarthritis were given either 2400 or 1200 mg of ibuprofen per day or 4000 mg of acetaminophen per day. They were evaluated after a washout period of three to seven days before the beginning of the study, and again after four weeks of treatment. The major measures of outcome included scores on the pain and disability scales of the Stanford Health Assessment Questionnaire (range of possible scores, 0 to 3), scores on the visual

1991 NEJM Controlled trial quality: predicted high

590. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. (Abstract)

Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. To test the hypothesis that non-steroidal anti-inflammatory drugs (NSAIDs) accelerate the progression of osteoarthritis by reducing synthesis of vasodilator prostaglandins, thereby diminishing joint perfusion, 105 osteoarthritis patients awaiting hip arthroplasty were treated prospectively with a strong or weak prostaglandin synthesis inhibitor, indomethacin or azapropazone, respectively. Pain and radiological (...) joint space were monitored during the period up to arthroplasty and the condition of the excised femoral head was determined. As judged by radiological and histopathological data, the two treatment groups were at a similar pathophysiological end-point when they came to arthroplasty. In the indomethacin group the affected hips lost joint space more rapidly than did the contralateral hips, a difference not seen in the azapropazone group. The patients receiving azapropazone, who had higher

1989 Lancet Controlled trial quality: uncertain

591. Controlled trial of homoeopathic treatment of osteoarthritis. (Abstract)

Controlled trial of homoeopathic treatment of osteoarthritis. In a double-blind, placebo-controlled crossover study to compare the homoeopathic remedy Rhus tox. 6X with fenoprofen in osteoarthritis of the hip and knee, fenoprofen was shown to have beneficial analgesic and anti-inflammatory effects which differed significantly from those of placebo. The effects of Rhus tox. 6X and placebo did not differ significantly. Patient preference was for fenoprofen. Side-effects were not severe but were

1983 Lancet Controlled trial quality: uncertain

592. Trolamine salicylate cream in osteoarthritis of the knee. (Abstract)

Trolamine salicylate cream in osteoarthritis of the knee. Twenty-five patients with symptomatic osteoarthritis (OA) of the knee were treated topically for one week with either 10% trolamine salicylate cream or placebo cream in a randomized double-blind crossover study. No significant difference was found in subjective or objective measures of pain relief between the treatment and control groups. Eight patients preferred "active" test cream, six preferred placebo, and 11 had no preference (...) . No side effects were reported. Topically applied 10% trolamine salicylate cream did not relieve the pain of OA of the knee any more than did placebo.

1982 JAMA Controlled trial quality: uncertain